Established in 2020 Friday, May 27, 2022


Common cold coronaviruses hinder antibody immune response to SARS-CoV-2 infection
Maureen McGargill, Ph.D., Department of Immunology, and graduate student Chun-Yang Lin. Image courtesy: St. Jude Children's Research Hospital.



MEMPHIS, TN.- Prior infection with coronaviruses that cause the common cold impedes the antibody immune response against SARS-CoV-2, the coronavirus responsible for COVID-19. The results from St. Jude Children's Research Hospital were published in the journal Cell Host and Microbe.

"The findings highlight an additional factor that contributes to the range of COVID-19 symptoms and their severity," said corresponding author Maureen McGargill, Ph.D., of the St. Jude Department of Immunology.

"The results also support COVID-19 vaccination, which seems to override the downside of prior immunity to common cold coronaviruses," she said.

Similar viruses, different antibodies
The viruses that cause COVID-19 and the common cold belong to the same large family of coronaviruses. By early in life, most people in the world have been infected with all four common cold coronaviruses, including two coronaviruses with features and structures with pronounced similarities to SARS-CoV-2.

"Prior to this study there were conflicting reports of how pre-existing immunity to common cold coronaviruses affected susceptibility to SARS-CoV-2 infection," McGargill said.

To account for individual differences in antibody levels to common cold coronaviruses, researchers measured antibody levels from the same person before and after SARS-CoV-2 infection and vaccination.

The results showed the viruses were similar enough that SARS-CoV-2 infection boosted levels of common cold coronaviruses antibodies, but those antibodies did not neutralize or block SARS-CoV-2 infection.

Investigators showed that high levels of pre-existing antibodies to common cold coronaviruses correlated with higher levels of SARS-CoV-2 antibodies after infection, an indicator of greater disease severity.

Additional findings
• Levels of pre-existing antibodies to common cold coronaviruses varied dramatically from person to person. The same was true following SARS-CoV-2 infection or vaccination.

• Higher baseline levels of betacoronavirus antibodies, or a greater increase of those antibodies following SARS-CoV-2 infection, were associated with increased antibodies to SARS-CoV-2. Elevated antibodies to the pandemic virus were linked to more severe disease as measured by antibody levels.

• Researchers did not find a similar association between baseline common cold coronavirus antibodies and SARS-CoV2 antibodies following COVID-19 vaccination. That suggests vaccines may induce an immune response strong enough to override the antibody production advantage of common cold coronaviruses.

• Investigators reported that production of SARS-CoV-2 neutralizing antibodies were inhibited in SARS-CoV-2-immunized mice that were previously immunized against common cold coronaviruses.







Today's News

January 14, 2022

Earliest human remains in eastern Africa dated to more than 230,000 years ago

Fastest DNA sequencing technique helps undiagnosed patients find answers in mere hours

New insights into seasons on a planet outside our solar system

Common cold coronaviruses hinder antibody immune response to SARS-CoV-2 infection

Scientists discover the gene that codes for the gold coloration of Midas cichlids

Scientists expand CRISPR-Cas9 genetic inheritance control in mammals

Dietrich Müller, renowned cosmic ray scientist, 1936-2021

Dengue virus makes mosquitos bite more often to better transmit disease

'Slushy' magma ocean led to formation of the Moon's crust

Researchers use ghost imaging to speed up X-ray fluorescence chemical mapping

UBC researchers lead $24 million project to treat spinal cord injury

Researchers reduce breast cancer metastasis in animal models by modifying tumor electrical properties

Why do we forget? New theory proposes 'forgetting' is actually a form of learning

Computer model seeks to explain the spread of misinformation, and suggest counter measures

Beating the odds in mutation's game of chance

Wearable air sampler assesses personal exposure to SARS-CoV-2

Newly-discovered planets will be 'swallowed' by their stars

Machine learning for morphable materials



 


Editor & Publisher: Jose Villarreal
Art Director: Juan José Sepúlveda Ramírez



Tell a Friend
Dear User, please complete the form below in order to recommend the ResearchNews newsletter to someone you know.
Please complete all fields marked *.
Sending Mail
Sending Successful